Thank you very much.
I'm glad you mentioned antimicrobial resistance, because it's certainly something we cannot turn our attention away from.
This is a question for, perhaps, Ms. Evans.
I notice that in budget 2022 the agency has been designated over $400 million related to surveillance and risk assessment. Given that this is Emergency Preparedness Week, I wonder if you could talk about how this funding might help to strengthen surveillance with a view to managing and responding to and preparing for potential future phases of this pandemic but also, equally as important, potentially other infectious disease threats and pandemics, as quickly as you can.
Thank you.